欧盟EMA药品数据库
(European Medicines Agency Authorisation of Medicines DataBase)
商品名称 通用名称 活性成分 产品号 上市许可持有人/公司名称 上市批准日期 授权状态
Quviviq daridorexant daridorexant hydrochloride EMEA/H/C/005634 Idorsia Pharmaceuticals Deutschland GmbH 2022/04/29 Authorised
Kapruvia difelikefalin difelikefalin EMEA/H/C/005612 Vifor Fresenius Medical Care Renal Pharma France 2022/04/25 Authorised
Padcev enfortumab vedotin Enfortumab vedotin EMEA/H/C/005392 Astellas Pharma Europe B.V. 2022/04/13 Authorised
Breyanzi lisocabtagene maraleucel CD19-directed genetically modified autologous cell-based product consisting of purified CD8+ T-cells (CD8+ cells), CD19-directed genetically modified autologous cell-based product consisting of purified CD4+ T cells (CD4+ cells) EMEA/H/C/004731 Bristol-Myers Squibb Pharma EEIG 2022/04/04 Authorised
Kimmtrak tebentafusp tebentafusp EMEA/H/C/004929 Immunocore Ireland Limited 2022/04/01 Authorised
Stimufend pegfilgrastim pegfilgrastim EMEA/H/C/004780 Fresenius Kabi Deutschland GmbH 2022/03/28 Authorised
Evusheld tixagevimab, cilgavimab tixagevimab, cilgavimab EMEA/H/C/005788 AstraZeneca AB 2022/03/25 Authorised
Dasatinib Accord dasatinib dasatinib EMEA/H/C/005446 Accord Healthcare S.L.U. 2022/03/24 Authorised
Dasatinib Accordpharma dasatinib dasatinib EMEA/H/C/005317 Accord Healthcare S.L.U. 2022/03/24 Authorised
Ontilyv opicapone opicapone EMEA/H/C/005782 Bial Portela & Companhia S.A. 2022/02/21 Authorised
Tepmetko tepotinib Tepotinib hydrochloride monohydrate EMEA/H/C/005524 Merck Europe B.V. 2022/02/16 Authorised
Kerendia finerenone Finerenone EMEA/H/C/005200 Bayer AG 2022/02/16 Authorised
Sapropterin Dipharma sapropterin Sapropterin dihydrochloride EMEA/H/C/005646 Dipharma B.V. 2022/02/16 Authorised
Sitagliptin / Metformin hydrochloride Mylan metformin hydrochloride, sitagliptin hydrochloride monohydrate metformin hydrochloride, sitagliptin hydrochloride monohydrate EMEA/H/C/005678 Mylan Ireland Limited 2022/02/16 Authorised
Oxbryta Voxelotor Voxelotor EMEA/H/C/004869 Global Blood Therapeutics Netherlands B. V. 2022/02/14 Authorised
Ngenla somatrogon somatrogon EMEA/H/C/005633 Pfizer Europe MA EEIG 2022/02/14 Authorised
Apexxnar pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed) Pneumococcal polysaccharide serotype 1, Pneumococcal polysaccharide serotype 3, Pneumococcal polysaccharide serotype 4, Pneumococcal polysaccharide serotype 5, Pneumococcal polysaccharide serotype 6A, Pneumococcal polysaccharide serotype 6B, Pneumococcal EMEA/H/C/005451 Pfizer Europe MA EEIG 2022/02/14 Authorised
Okedi risperidone Risperidone EMEA/H/C/005406 Laboratorios Farmacéuticos Rovi, S.A. 2022/02/14 Authorised
Saphnelo anifrolumab anifrolumab EMEA/H/C/004975 AstraZeneca AB 2022/02/14 Authorised
Paxlovid (1R,2S,5S)-N-((1S)-1-Cyano-2-((3S)-2-oxopyrrolidin-3-yl)ethyl)-3-((2S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido) butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide, ritonavir (1R,2S,5S)-N-((1S)-1-Cyano-2-((3S)-2-oxopyrrolidin-3-yl)ethyl)-3-((2S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido) butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide, ritonavir EMEA/H/C/005973 Pfizer Europe MA EEIG 2022/01/28 Authorised

数据库说明:

©2006-2022 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase